Stay updated on BI 695500 Clinical Trial in RA: Efficacy, PK, Safety
Sign up to get notified when there's something new on the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page.

Latest updates to the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record, and the view appears to present a minimal header/footer with the error message, making the previously available study details inaccessible in this view.SummaryDifference18%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedA new page revision tag, Revision: v3.6.6, appears replacing Revision: v3.6.5, indicating an update to the page's revision history.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded a Synopsis Link and sponsor attribution (Boehringer Ingelheim) to the Study Details page, along with a 'Helpful Links Provided by' label and a note about drug and device information, study documents, and other helpful links. These changes provide direct access to official materials and clarify the study's sponsor.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision label on the page was updated to v3.6.5, signaling a newer version of the page content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe Ukraine study site location spelling was updated to Zaporizhzhya, Ukraine, 69600, replacing Zaporizhzhia, Ukraine, 69600.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page’s revision tag was updated from v3.6.3 to v3.6.4, indicating a minor backend or documentation update.SummaryDifference0.0%

Stay in the know with updates to BI 695500 Clinical Trial in RA: Efficacy, PK, Safety
Enter your email address, and we'll notify you when there's something new on the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page.